VBI Vaccines (VBIV)

VBI Vaccines (VBIV) Stock Price & Analysis


VBIV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.24 - $1.86
Previous Close$0.29
Average Volume (3M)939.71K
Market Cap
Enterprise Value$63.38M
Total Cash (Recent Filing)$62.63M
Total Debt (Recent Filing)$52.23M
Price to Earnings (P/E)-0.6
May 08, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding230,648,396
10 Day Avg. Volume822,056
30 Day Avg. Volume939,709
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)5.86
Price to Sales (P/S)178.13
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue58.58
Enterprise Value/Gross Profit-6.22
Enterprise Value/Ebitda-0.60
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was VBI Vaccines’s price range in the past 12 months?
VBI Vaccines lowest stock price was $0.23 and its highest was $1.86 in the past 12 months.
    What is VBI Vaccines’s market cap?
    Currently, no data Available
    When is VBI Vaccines’s upcoming earnings report date?
    VBI Vaccines’s upcoming earnings report date is May 08, 2023 which is in 44 days.
      How were VBI Vaccines’s earnings last quarter?
      VBI Vaccines released its earnings results on Mar 13, 2023. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.01.
        Is VBI Vaccines overvalued?
        According to Wall Street analysts VBI Vaccines’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does VBI Vaccines pay dividends?
          VBI Vaccines pays a Notavailable dividend of $4.52 which represents an annual dividend yield of N/A. See more information on VBI Vaccines dividends here
            What is VBI Vaccines’s EPS estimate?
            VBI Vaccines’s EPS estimate is -$0.08.
              How many shares outstanding does VBI Vaccines have?
              VBI Vaccines has 258,257,500 shares outstanding.
                What happened to VBI Vaccines’s price movement after its last earnings report?
                VBI Vaccines reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went up 2.857%.
                  Which hedge fund is a major shareholder of VBI Vaccines?
                  Among the largest hedge funds holding VBI Vaccines’s share is Perceptive Advisors LLC. It holds VBI Vaccines’s shares valued at 20M.


                    VBI Vaccines Stock Smart Score

                    The VBI Vaccines stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    VBI Vaccines

                    VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA.


                    Top 5 ETFs holding VBIV

                    Currently, no data available
                    Please return soon. This page is being updated.
                    Up to five ETFs with an Outperform Smart Score that hold VBIV. The ETFs are listed according to market value of VBIV within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Tenaya Therapeutics
                    Oric Pharmaceuticals
                    Anixa Biosciences
                    Precision BioSciences
                    Alaunos Therapeutics

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis